Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-049/04
A61K-051/12
A61K-049/18
A61K-049/22
출원번호
US-0693190
(2015-04-22)
등록번호
US-9597419
(2017-03-21)
발명자
/ 주소
Fritz, Ulf
Fritz, Olaf
Gordy, Thomas A.
Wojcik, Ronald
Blümmel, Jacques
Küller, Alexander
출원인 / 주소
Boston Scientific Limited
인용정보
피인용 횟수 :
0인용 특허 :
222
초록▼
Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include polybis(trifluoroethoxy)phosphazene and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a
Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include polybis(trifluoroethoxy)phosphazene and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Such particles may be provided to a user in specific selected sizes to allow for selective embolization of certain sized blood vessels or localized treatment with an active component agent in specific clinical uses. Microspheres of the present invention may further be provided with physical and/or chemical enhancements within the particles' cores to enhance visualization of the embolized tissue using a variety of medical imaging modalities, including conventional radiography, fluoroscopy, tomography, computerized tomography, ultrasound, scintillation, magnetic resonance, or other imaging technologies.
대표청구항▼
1. A method of performing a selective embolization, the method comprising: a) selecting a targeted tissue within a mammalian patient; andb) delivering to the targeted tissue one or more first particles, the first particles each comprising a core and a coating;wherein the first particle core comprise
1. A method of performing a selective embolization, the method comprising: a) selecting a targeted tissue within a mammalian patient; andb) delivering to the targeted tissue one or more first particles, the first particles each comprising a core and a coating;wherein the first particle core comprises a first acrylic-based hydrogel polymer; andthe first particle coating comprises a poly[bis(trifluoroethoxy)phosphazene] and/or a derivative thereof. 2. The method of claim 1, wherein the acrylic-based hydrogel polymer comprises a polymethyl methacrylate hydrolyzed with potassium hydroxide. 3. The method of claim 1, wherein the poly[bis(trifluoroethoxy)phosphazene] is poly[bis(2,2,2-trifluoroethoxy)]phosphazene or a derivative of poly[bis(2,2,2-trifluoroethoxy)]-phosphazene. 4. The method of claim 1, wherein the first particle core comprises a contrast agent. 5. The method of claim 4, wherein the contrast agent is selected from Diatrizoate, Metrizoate, Ioxaglate, Iopamidol, Iohexyl, Ioxilan, Iopromide, Iodixanol, Ioxitalamin, or a combination thereof. 6. The method of claim 4, wherein the contrast agent is selected from 67Ga, 68Ga, 123I, 126I, 131I, 132I, 133I, 111In, 113In, 201T1, 203T1, 3H, 11C, 14C, 13N, 18F, 22Na, 24Na, 31Si, 32P, 35S, 36Cl, 38Cl, 42K, 45Ca, 51Cr, 52Mn, 54Mn, 55Fe, 59Fe, 60Co, 63Zn, 65Zn, 86Zn, 82Br, 85K, 85Kr, 89Sr, 99Tc, 99mTc, 99mRe, 105Re, 105Re, 121mTe, 122mTe, 125mRe, 137Cs, 165Tm, 167Tm, 168Tm, 81mKr, 33Xe, 90Y, 3Bi, 77Br, 18F, 95Ru, 97Ru, 103Ru, 105Ru, 107Hg, 203Hg, 182Ta, 192Ir, 198Au, or a combination thereof. 7. The method of claim 4, wherein the contrast agent is selected from a tantalum compound, a gadolinium compound, a samarium-compound, a paramagnetic rare earth compound, ferric chloride, ferric ammonium citrate, gadolinium-DTPA, gadolinium-DOTA, gadolinium-EDTA, GdCl3, Gadodiamide, Gadoteridol, gadopentetate dimeglumine, a Cr(III) compound, a manganese compound, Mn(III)TPPS4 (manganese(III) tetra-[4-sulfanatophenyl]porphyrin), Fe(III)TPPS4 (iron(III) tetra-[4-sulfanatophenyl]porphyrin), manganese dichloride, iron(III) ethylenebis-(2-hydroxyphenylglycine), 99mTc-iminodiacetate, chromium diethyl HIDA meglumine, gadobenate dimeglumine, manganese(II)-dipyridoxal diphosphate, gadolinium oxide, a superparamagnetic iron oxide, a small particle iron oxide, an ultrasmall supermagnetic particle iron oxide, or an ultrasmall particle iron oxide. 8. The method of claim 1, further comprising: c) confirming delivery of the first particles to the targeted tissue using a suitable imaging technology. 9. The method of claim 8, further comprising: d) delivering to the targeted tissue one or more second particles, the second particles being larger than the first particles, each second particle comprising a core and a coating,wherein the second particle core comprises a second acrylic-based hydrogel polymer; andthe second particle coating comprises poly[bis(trifluoroethoxy)phosphazene] and/or a derivative thereof;wherein the second acrylic-based hydrogel polymer is the same as or different from the first acrylic-based hydrogel polymer, and the second particles travel more proximally in the targeted tissue than the first particles. 10. The method of claim 9, wherein the second particle core further comprises a second contrast agent wherein the second contrast agent is the same or different from the first contrast agent. 11. The method of claim 9, further comprising: e) identifying the retardation of blood flow and the beginning of vascular saturation in the targeted tissue. 12. The method of claim 9, further comprising: f) delivering to the targeted tissue one or more third particles, the third particles being larger than the first and second particles, each third particle comprising a core and a coating,wherein the third particle core comprises a third acrylic-based hydrogel polymer; andwherein the third particle coating comprises poly[bis(trifluoroethoxy)phosphazene] and/or a derivative thereof;wherein the third acrylic-based hydrogel polymer is the same as or different from the first and second acrylic-based hydrogel polymer, and the third particles travel more proximally in the targeted tissue than the first or second particles. 13. The method of claim 12, wherein the third particle core further comprises a third contrast agent wherein the third contrast agent is the same or different from the first and/or second contrast agent. 14. The method of claim 12, further comprising: g) identifying an endpoint of a desired devascularization in the targeted tissue. 15. The method of claim 12, further comprising: g) determining the distance between proximal and distal embolization regions in the targeted tissue; andh) assessing the effect of the different particles in the embolization regions in the targeted tissue. 16. The method of claim 1, wherein the particles are delivered to the targeted tissue through blood vessels. 17. The method of claim 1, wherein delivery of the first particle to the targeted tissue results in devascularization of the targeted tissue.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (222)
Miller,Paul Leonard, Active tissue augmentation materials and method.
Leshchiner Edward (Cresskill NJ) Balazs Endre A. (Fort Lee NJ) Larsen Nancy E. (Highland Mills NY) Leshchiner Adelva (Cresskill NJ), Biocompatible viscoelastic gel slurries, their preparation and use.
Leshchiner Edward (Cresskill NJ) Balazs Endre A. (Fort Lee NJ) Larsen Nancy E. (Highland Mills NY) Leshchiner Adelya (Cresskill NJ), Biocompatible viscoelastic gel slurries, their preparation and use.
Song Soo-Chang,KRX ; Sohn Youn Soo,KRX ; Lee Bae Hoon,KRX ; Lee Sang Beom,KRX, Biodegradable and thermosensitive polyphosphazenes and their preparation method.
Polson Alan M. (Fort Collins CO) Swanbom Deryl D. (Fort Collins CO) Dunn Richard L. (Fort Collins CO) Cox Charles P. (Fort Collins CO) Norton Richard L. (Fort Collins CO) Lowe Bryan K. (Fort Collins , Biodegradable implant precursor.
Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David D. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David P. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
Norton Richard L. (Fort Collins CO) Knight Stephen Michael Gregory (Fort Collins CO) Tipton Arthur J. (Birmingham AL), Biodegradable polymeric composition.
Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable system for regenerating the periodontium.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Biologically inert, biocompatible-polymer conjugates.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates containing an ether linkage.
Schlameus Herman W. (San Antonio TX) Fox William C. (San Antonio TX) Mangold Donald J. (San Antonio TX) Triplett Robert G. (Dallas TX) Holt George R. (San Antonio TX) Aufdemorte Thomas B. (Lakeway TX, Composition and method of promoting hard tissue healing.
Olof Mikael Trollsas ; Donald G. Wallace ; Frank A. DeLustro, Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
Berg,Richard; Falcone,Samuel; Oppelt,William G.; Cortese,Stephanie M., Compositions of polyacids and polyethers and methods for their use as dermal fillers.
Annan Nikoi ; Reynolds Charles Howard ; Shaber Steven Howard ; Langenmayr Eric Jon, Contrast enhancing agent having a polymeric core and polymeric shell.
Eury Robert P. (Cupertino CA) Garguilo Darlene (Fremont CA) Villareal Plaridel (San Jose CA), Drug loaded polymeric material and method of manufacture.
Conston Stanley R. (San Carlos CA) Dapper Gregory S. (Newark CA) Murphy Aileen L. (Menlo Park CA) Raeder-Devens Jennifer (Oakland CA) Yamamoto Ronald (San Francisco CA), Embolization plugs for blood vessels.
Cohen Smadar (Petach-Tickva MA ILX) Andrianov Alexander K. (Belmont MA) Wheatley Margaret (Media PA) Allcock Harry R. (State College PA) Langer Robert S. (Newton MA), Gas-filled polymeric microbubbles for ultrasound imaging.
Takahashi Toru (Shizuoka-ken JPX) Nakamura Hideki (Kanagawa-ken JPX) Goto Katsuya (Fukuoka-ken JPX), High polymer gel and vascular lesion embolizing material comprising the same.
Andrianov Alexander K. (Belmont MA) Jenkins Sharon A. (Peabody MA) Payne Lendon G. (Arlington MA) Roberts Bryan E. (Cambridge MA), Hydrogel microencapsulated vaccines.
Boschetti Egisto (Chatou FRX), Hydrophilic copolymers based on N-[tris(hydroxymethyl)methyl]-acrylamide, processes for their preparation, aqueous gels.
Hench Larry L.,GB2 ; West Jon K. ; LaTorre Guy ; Wilson June,GB2 ; Toreki ; III William ; Batich Christopher, Injectable bio-active glass in a dextran suspension.
Hench Larry L.,GBX ; West Jon K. ; LaTorre Guy ; Wilson June,GBX ; Toreki ; III William ; Batich Christopher, Injectable bio-active glass in a dextran suspension.
Wallace Donald G. (Menlo Park CA) McMullin Hugh (Pacifica CA) Chu George (Cupertino CA), Injectable ceramic compositions and methods for their preparation and use.
Wallace Donald G. (Menlo Park) McMullin Hugh (Pacifica) Chu George (Cupertino CA), Injectable ceramic compositions and methods for their preparation and use.
Oppenheim ; Richard Charles ; Marty ; Jennifer Joy ; Speiser ; Peter, Injectable compositions, nanoparticles useful therein, and process of manufacturing same.
Wallace Donald G. (Menlo Park CA) Reihanian Hertsel (San Francisco CA) Pharriss Bruce B. (Palo Alto CA) Braun William G. (Los Altos CA), Injectable implant composition having improved intrudability.
Scopelianos Angelo G. ; Arnold Steven C. ; Bezwada Rao S. ; Roller Mark B. ; Huxel Shawn T., Injectable microdipersions for soft tissue repair and augmentation.
Scopelianos Angelo G. (Whitehouse Station NJ) Arnold Steven C. (Sparta NJ) Bezwada Rao S. (Whitehouse Station NJ) Roller Mark B. (North Brunswick NJ) Huxel Shawn T. (Lakehurst NJ), Injectable microdispersions for soft tissue repair and augmentation.
Rhee Woonza M. ; Berg Richard A. ; Chu George H. ; DeLustro Frank A. ; Jolivette Dan M. ; McCullough Kimberly A., Injectable or implantable biomaterials for filling or blocking lumens and voids of the body.
Cohen Smadar (12 Tfuzoth Israel Petach-Tickya ILX 49581) Bano Carmen (Juardia Civil 23 ; esc. 5 46020 Valencia PA ESX) Visscher Karyn B. (800-14 Stratford Dr. State College PA 16801) Chow Marie B. (5, Ionically cross-linked polymeric microcapsules.
Cohen Smadar (Petach-Tickya ILX) Bano Carmen (Valencia PA ESX) Visscher Karyn B. (State College PA) Chow Marie (Brookline MA) Allcock Harry R. (State College PA) Langer Robert S. (Newton MA), Ionically cross-linked polymeric microcapsules.
Polson Alan M. ; Swanbom Deryl D. ; Dunn Richard L. ; Cox Charles P. ; Norton Richard L. ; Lowe Bryan K. ; Peterson Kenneth S., Method and composition for treating a bone tissue defect.
Frondoza, Carmelita G.; Hungerford, David S.; Shikani, Alan H.; Domb, Abraham J.; Fink, David J.; Bloom, Leonard, Method for composite cell-based implants.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Method of augmenting tissue with collagen-polymer conjugates.
Angelo G. Scopelianos ; Steven C. Arnold ; Rao S. Bezwada ; Mark B. Roller ; Shawn T. Huxel ; Robert J. Tannhauser, Microdispersions for coating surgical devices.
Bellare, Anuj; Fitz, Wolfgang; Gomoll, Andreas H.; Scott, Richard D.; Thornhill, Thomas S., Nanocomposite surgical materials and method of producing them.
Karen L. Wooley ; K. Bruce Thurmond, II ; Haiyong Huang, Particles comprising amphiphilic copolymers, having a crosslinked shell domain and an interior core domain, useful for pharmaceutical and other applications.
Low Samuel B. (Gainesville FL) Fetner Alan E. (Gainesville FL) Clark ; Jr. Arthur E. (Gainesville FL) Hench Larry L. (Gainesville FL) Wilson-Hench June (Gainesville FL), Periodontal osseous defect repair.
Allcock Harry R. (State College PA) Andrianov Alexander K. (Belmont MA) Langer Robert S. (Newton MA) Visscher Karyn B. (State College PA), Phosphazene polyelectrolytes as immunoadjuvants.
Andrianov Alexander K. (Belmont MA) Jenkins Sharon A. (Peabody MA) Payne Lendon G. (Arlington MA) Roberts Bryan E. (Cambridge MA), Phosphazene polyelectrolytes as immunoadjuvants.
Laurencin Cato T. ; El-Amin Saadiq ; Ambrosio Archel M. A. ; Pucher Shawn R. ; Allcock Harry R., Poly(organophosphazene) matrices for bone replacement.
Aniuk Lawrence M. (Santa Clara CA) Dieck Ronald L. (Irving CA) Hardy Dwayne (San Mateo CA), Polymeric article having high tensile energy to break when hydrated.
Cohen Smadar (Petach-Tickva ILX) Andrianov Alexander K. (Belmont MA) Wheatley Margaret (Media PA) Allcock Harry R. (State College PA) Langer Robert S. (Newton MA), Polymeric microparticles containing agents for imaging.
Daniels John R. (Menlo Park CA) Knapp Terry R. (Santa Clara CA), Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution.
Vanderhoff John W. ; Lu Cheng Xun ; Lee Clarence C. ; Tsai Chi-Chun, Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained.
Vanderhoff, John W.; Lu, Cheng Xun; Lee, Clarence C.; Tsai, Chi-Chun, Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained.
Ashman, Arthur; Bruins, Paul F., Process of making implantable prosthesis material of modified polymeric acrylic (PMMA) beads coated with PHEMA and barium sulfate.
Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Osborne Thomas A. ; Kozma Thomas G. ; Roberts Joseph W. ; Voorhees ; III William D., Silver implantable medical device.
Caravel Jean-Baudoin,FRX, Supple implantable prosthesis used in surgery for increasing the volume of or reconstructing soft tissue, notably a breast prosthesis, and its method of manufacture.
Allcock Harry R. ; Morrissey Christopher T. ; Manners Ian,CAX ; Honeyman Charles H. ; Nelson James M. ; Crane Chester A. ; Reeves Scott D. ; Primrose A. Paul ; Hartle Thomas J. ; Prange R., Synthesis polyphosphazenes with controlled molecular weight and polydisperity.
Ersek Robert A. (62 Pascal Austin TX 78746) Beisang ; III Arthur A. (5883 Carlson St. Shoreview MN 55126) Beisang Arthur A. (1300 Ingerson Rd. Arden Hills MN 55112), Textured micro implants.
Ersek Robert A. (62 Pascal Austin TX 78746) Beisang Arthur A. (1035 Lake Beach Dr. Shoreview MN 55126) Beisang ; III Arthur A. (4 Falcon La. St. Paul MN 55127-6317), Textured micro implants.
Gombotz Wayne R. (Lexington MA) Healy Michael S. (E. Bridgewater MA) Brown Larry R. (Newton MA), Very low temperature casting of controlled release microspheres.
Allcock Harry R. (State College PA) Austin Paul E. (Williamstown WV) Kwon Sukky (University Park PA), Water-soluble phosphazene polymers having pharmacological applications.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.